Researchers developed AI models using EHR and patient-reported outcomes to identify cancer survivors at high risk for emergency visits and worsening symptoms.
Key Details
- 1Study by Sylvester Comprehensive Cancer Center (University of Miami) published in JCO Clinical Cancer Informatics (May 2026).
- 2AI models analyzed data from over 25,000 cancer survivors followed for three years.
- 3Combined EHR and PRO data to predict unplanned healthcare use (ED visits, hospitalizations) and elevated symptom burden.
- 4Recent clinical activity helped predict acute events, while long-term PRO trends improved symptom prediction.
- 5Adding PROs nearly doubled symptom forecasting accuracy compared to using clinical data alone.
- 6Top 10% of risk-flagged patients accounted for half of downstream healthcare events and symptom episodes.
Why It Matters
Integrating AI-based risk stratification into survivorship care could enable earlier, more targeted interventions for cancer survivors. This demonstrates the evolving potential of medical AI to support proactive patient management across radiology-adjacent fields.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.
•EurekAlert
AI-Guided Handheld Cardiac Ultrasound Reduces Referrals and Costs in Spain
AI-guided handheld cardiac ultrasound enables primary care physicians to detect heart failure, reducing specialist referrals and saving costs.
•EurekAlert
AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.